Insider · CIK 0001815595
Jungles Steven J
Reports to the SEC for 1 company · BOSTON, MA
Transactions
4
Companies
1
Filings
3
CIK
0001815595
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-03-04 | Inozyme Pharma, Inc.Stock Option (right to buy)A Award | — |
| 2021-01-13 | Inozyme Pharma, Inc.Stock Option (right to buy)A Award | — |
| 2020-07-28 | Inozyme Pharma, Inc.C Conversion | — |
| 2020-07-28 | Inozyme Pharma, Inc.Series A Convertible Preferred StockC Conversion | — |
Recent filings
- 4Jungles Steven J0001209191-21-021487SEC(opens sec.gov)
- 4Jungles Steven J0001209191-21-003598SEC(opens sec.gov)
- 4Jungles Steven J0000899243-20-020570SEC(opens sec.gov)
Companies
Address
C/O INOZYME PHARMA, INC. 321 SUMMER STREET, SUITE 400
BOSTON, MA, 02210